Neutralization of Marinobufagenin Demonstrates Efficacy In Vitro and In Vivo in Models of Pre-Eclampsia., PMID:40299324
Neutralization of Marinobufagenin Demonstrates Efficacy In Vitro and In Vivo in Models of Pre-Eclampsia., PMID:40299324
Antibody to Endogenous Cardiotonic Steroid Reverses Vascular Fibrosis and Restores Vasorelaxation in Chronic Kidney Disease., PMID:39201581
Antibody to Endogenous Cardiotonic Steroid Reverses Vascular Fibrosis and Restores Vasorelaxation in Chronic Kidney Disease., PMID:39201581
Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1., PMID:39097927
Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1., PMID:39097927
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines., PMID:38349280
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines., PMID:38349280
Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling., PMID:38036617
Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling., PMID:38036617
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity., PMID:37527039
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity., PMID:37527039
Characteristics and treatment responses of immune thrombocytopenia in patients with primary Sjögren syndrome., PMID:37506503
Characteristics and treatment responses of immune thrombocytopenia in patients with primary Sjögren syndrome., PMID:37506503
Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab., PMID:37309201
Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab., PMID:37309201
[Anti-MBG crescentic glomerulonephritis with negative immunofluorescence: case report and literature review]., PMID:37179475
[Anti-MBG crescentic glomerulonephritis with negative immunofluorescence: case report and literature review]., PMID:37179475
eGFP as an All-in-One Tag for Purification of Membrane Proteins., PMID:37093475
eGFP as an All-in-One Tag for Purification of Membrane Proteins., PMID:37093475
Early computational detection of potential high-risk SARS-CoV-2 variants., PMID:36774893
Early computational detection of potential high-risk SARS-CoV-2 variants., PMID:36774893
Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatment., PMID:36174034
Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatment., PMID:36174034
Improved Survival of Lymphoma Patients with COVID-19 in the Modern Treatment and Vaccination Era., PMID:36077782
Improved Survival of Lymphoma Patients with COVID-19 in the Modern Treatment and Vaccination Era., PMID:36077782
Purpose-Built Immunoinformatics for BcR IG/TR Repertoire Data Analysis., PMID:35622343
Purpose-Built Immunoinformatics for BcR IG/TR Repertoire Data Analysis., PMID:35622343
Introducing Cysteines into Nanobodies for Site-Specific Labeling., PMID:35157281
Introducing Cysteines into Nanobodies for Site-Specific Labeling., PMID:35157281
Movement disorders associated with neuronal antibodies: a data-driven approach., PMID:35024921
Movement disorders associated with neuronal antibodies: a data-driven approach., PMID:35024921
Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients., PMID:34918048
Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients., PMID:34918048
Medication-induced Pulmonary Injury: A Scenario- and Pattern-based Approach to a Perplexing Problem., PMID:34826256
Medication-induced Pulmonary Injury: A Scenario- and Pattern-based Approach to a Perplexing Problem., PMID:34826256
Alterations in Faecal Microbiota and Elevated Levels of Intestinal IgA Following Oral Administration of Lacticaseibacillus casei in mice., PMID:34676502
Alterations in Faecal Microbiota and Elevated Levels of Intestinal IgA Following Oral Administration of Lacticaseibacillus casei in mice., PMID:34676502
Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail., PMID:34201591
Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail., PMID:34201591
Nanoscale spatial dependence of avidity in an IgG1 antibody., PMID:34135438
Nanoscale spatial dependence of avidity in an IgG1 antibody., PMID:34135438
Structural insights into the inhibition of glycine reuptake., PMID:33658720
Structural insights into the inhibition of glycine reuptake., PMID:33658720
Anca-positive vasculitis with full-house nephropathy, an unusual association: a case report and review of literature., PMID:33501927
Anca-positive vasculitis with full-house nephropathy, an unusual association: a case report and review of literature., PMID:33501927
A Complement C3-Specific Nanobody for Modulation of the Alternative Cascade Identifies the C-Terminal Domain of C3b as Functional in C5 Convertase Activity., PMID:32938727
A Complement C3-Specific Nanobody for Modulation of the Alternative Cascade Identifies the C-Terminal Domain of C3b as Functional in C5 Convertase Activity., PMID:32938727
An Ultrahigh-Affinity Complement C4b-Specific Nanobody Inhibits In Vivo Assembly of the Classical Pathway Proconvertase., PMID:32769120
An Ultrahigh-Affinity Complement C4b-Specific Nanobody Inhibits In Vivo Assembly of the Classical Pathway Proconvertase., PMID:32769120
Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complement., PMID:32599335
Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complement., PMID:32599335
A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system., PMID:32376685
A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system., PMID:32376685
The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus., PMID:31950036
The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus., PMID:31950036
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties., PMID:31879340
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties., PMID:31879340
[ANCA and anti-MBG double-positive vasculitis: An update on the clinical and therapeutic specificities and comparison with the two eponymous vasculitis]., PMID:31839271
[ANCA and anti-MBG double-positive vasculitis: An update on the clinical and therapeutic specificities and comparison with the two eponymous vasculitis]., PMID:31839271
[Review on anti-glomerular basement membrane disease or Goodpasture's syndrome]., PMID:31776042
[Review on anti-glomerular basement membrane disease or Goodpasture's syndrome]., PMID:31776042
Milk osteopontin retains integrin-binding activity after in vitro gastrointestinal transit., PMID:31733850
Milk osteopontin retains integrin-binding activity after in vitro gastrointestinal transit., PMID:31733850
Antibody against Na/K-ATPase Inhibitor Lowers Blood Pressure and Increases Vascular Fli1 in Experimental Preeclampsia., PMID:31713584
Antibody against Na/K-ATPase Inhibitor Lowers Blood Pressure and Increases Vascular Fli1 in Experimental Preeclampsia., PMID:31713584
Enzymatic activity in single cells., PMID:31668235
Enzymatic activity in single cells., PMID:31668235
Isolation and Characterization of Nanobodies against a Zinc-Transporting P-Type ATPase., PMID:31544889
Isolation and Characterization of Nanobodies against a Zinc-Transporting P-Type ATPase., PMID:31544889
Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats., PMID:31415452
Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats., PMID:31415452
A Randomized Study to Compare the Effects of Once-Weekly Dulaglutide Injection and Once-Daily Glimepiride on Glucose Fluctuation of Type 2 Diabetes Mellitus Patients: A 26-Week Follow-Up., PMID:31183384
A Randomized Study to Compare the Effects of Once-Weekly Dulaglutide Injection and Once-Daily Glimepiride on Glucose Fluctuation of Type 2 Diabetes Mellitus Patients: A 26-Week Follow-Up., PMID:31183384
Lipidoid-siRNA Nanoparticle-Mediated IL-1β Gene Silencing for Systemic Arthritis Therapy in a Mouse Model., PMID:31153827
Lipidoid-siRNA Nanoparticle-Mediated IL-1β Gene Silencing for Systemic Arthritis Therapy in a Mouse Model., PMID:31153827
Intracoronary or intravenous abciximab after aspiration thrombectomy in patients with STEMI undergoing primary percutaneous coronary intervention., PMID:30460974
Intracoronary or intravenous abciximab after aspiration thrombectomy in patients with STEMI undergoing primary percutaneous coronary intervention., PMID:30460974
Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors., PMID:30409910
Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors., PMID:30409910
Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia., PMID:30104471
Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia., PMID:30104471
Role of endogenous digitalis-like factors in the clinical manifestations of severe preeclampsia: a sytematic review., PMID:29930141
Role of endogenous digitalis-like factors in the clinical manifestations of severe preeclampsia: a sytematic review., PMID:29930141
A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement., PMID:29497000
A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement., PMID:29497000
Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction., PMID:29295972
Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction., PMID:29295972
[A giant cell arteritis revealing a Goodpasture's syndrome]., PMID:29290619
[A giant cell arteritis revealing a Goodpasture's syndrome]., PMID:29290619
On-slide detection of enzymatic activities in selected single cells., PMID:28872165
On-slide detection of enzymatic activities in selected single cells., PMID:28872165
Impact of metric and sample size on determining malaria hotspot boundaries., PMID:28401903
Impact of metric and sample size on determining malaria hotspot boundaries., PMID:28401903
Higher-Order Structure in Bacterial VapBC Toxin-Antitoxin Complexes., PMID:28271484
Higher-Order Structure in Bacterial VapBC Toxin-Antitoxin Complexes., PMID:28271484
Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction., PMID:27467458
Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction., PMID:27467458
A Camelid-derived Antibody Fragment Targeting the Active Site of a Serine Protease Balances between Inhibitor and Substrate Behavior., PMID:27226628
A Camelid-derived Antibody Fragment Targeting the Active Site of a Serine Protease Balances between Inhibitor and Substrate Behavior., PMID:27226628
For research use only. Not for human or drug use.
